Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients
Open Access
- 1 April 2016
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , 911-917
Abstract
No abstract availableKeywords
Funding Information
- National Pancreas Foundation (1K23DK088832)
- National Institutes of Health (1K23DK088832)
This publication has 22 references indexed in Scilit:
- Rectal NSAIDs for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trialsThe Surgeon, 2014
- A Meta-Analysis on the Role of Rectal Diclofenac and Indomethacin in the Prevention of Post–Endoscopic Retrograde Cholangiopancreatography PancreatitisPancreas, 2014
- Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysisGastrointestinal Endoscopy, 2012
- Burden of Gastrointestinal Disease in the United States: 2012 UpdateGastroenterology, 2012
- Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensusGut, 2012
- Rectal Indomethacin to Prevent Post-ERCP PancreatitisNew England Journal of Medicine, 2012
- A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP PancreatitisNew England Journal of Medicine, 2012
- A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitisGut, 2008
- Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized studyGastrointestinal Endoscopy, 2003
- Complications of Endoscopic Biliary SphincterotomyNew England Journal of Medicine, 1996